Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $873.42M.
ENTERPRISE VALUE (EV)
$873.42M
Damora Therapeutics, Inc.
Market Cap
$1.13B
Enterprise Value (EV)
$873.42M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.13B | $873.42M |
| Kardigan, Inc. (KARD)vs › | $1.13B | $763.95M |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.14B | $889.39M |
| Harrow Health, Inc. (HROW)vs › | $1.12B | $1.34B |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | $1.57B |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | $1.40B |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | $997.22M |
| Nektar Therapeutics (NKTR)vs › | $1.18B | $1.27B |
| IRadimed Corporation (IRMD)vs › | $1.09B | $1.03B |
| MannKind Corporation (MNKD)vs › | $1.19B | $1.47B |
Market Cap
$1.13B
Total Debt
$0.00
Cash
$257.62M
Enterprise Value
$873.42M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
